Written Question·Department of Health and Social Care·UIN 77442

Abiraterone

Tabled: 15 September 2025
Answered: 13 October 2025

Question

Cameron Thomas

IndependentTewkesbury

To ask the Secretary of State for Health and Social Care, what recent assessment his Department has made of the geographic differences in the cost of abiraterone for high-risk prostate cancer patients in England.

Answer

Karin Smyth
The procurement of abiraterone for secondary care is currently part of NHS England’s generic wave tender structure. NHS England tenders two regions out of six at a time to encourage competition and to ensure supply chain resilience, awarding the top two c...

This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 77442) →

Partner sites